Clinical Trial Update: Vactosertib in Combination with Pembrolizumab in Metastatic Colorectal or Gastric Cancer [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update on Vactosertib combined with pembrolizumab for metastatic colorectal cancer and gastric/gastroesophageal junction adenocarcinoma in Phase …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Gastric Cancer
• Gastroesophageal Junction Adenocarcinoma

Drugs mentioned

• Pembrolizumab (pembrolizumab)
• Vactosertib (Vactosertib)

Snippet

Sponsor: MedPacto, Inc. | Conditions: Metastatic Colorectal Cancer, Gastric Cancer | Phase 1, Phase 2 | Status: COMPLETED